Medical Condition News

RSS

PixelOptics launches world's first electronically-focusing prescription eyewear

Following an award-winning preview at the Consumer Electronics Show in Las Vegas, PixelOptics today announced the formal introduction of emPower!, the world's first electronically-focusing prescription eyewear, at Vision Expo East in New York this week.

18 Mar 2011

Retina Implant to join with Wills Eye for U.S. artificial vision clinical trial

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced that they will partner with the Wills Eye Institute in Philadelphia as the lead U.S. clinical trial investigator site.

18 Mar 2011

Experts to present latest information on multiple myeloma at Patient Symposium

The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.

18 Mar 2011

Autism Speaks supports ICM-9-CM diagnostic code for ASD detection in children

With increasing frequency, parents of children with autism spectrum disorder report the terrible consequences that can occur when their children wander or unexpectedly run away.

18 Mar 2011

Researchers discover a type of 'cellular bilingualism' in brain

A team of researchers from the University of Montreal and McGill University have discovered a type of "cellular bilingualism" - a phenomenon that allows a single neuron to use two different methods of communication to exchange information.

18 Mar 2011

Medicare officials signal no payment changes on anemia drugs

Medicare officials signaled Wednesday that they will not change a payment policy for biotech drugs made by Amgen and Johnson & Johnson when they are used to treat anemia in kidney disease patients, despite data suggesting heart risks for those patients.

18 Mar 2011

GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference

Genomic Health, Inc. today announced results from nine studies utilizing the Oncotype DX test in early-stage breast cancer patients at the 12th Annual St. Gallen International Breast Cancer Conference in St. Gallen, Switzerland.

18 Mar 2011

Non-adherence to chronic opioid therapy increases healthcare costs and hospital days

Patients undergoing opioid therapy for chronic pain who may not be following their prescription regimen have significantly higher overall healthcare costs, Ameritox Ltd. announced recently. The study was published in The American Journal of Managed Care.

18 Mar 2011

AANMA survey details the impact of asthma and allergies on patients and their families

Today Allergy & Asthma Network Mothers of Asthmatics released a first-of-its-kind survey detailing the impact of asthma and allergies on the people who cope with it every day.

18 Mar 2011

Nature's Health announces record sales of 145% for Australian Dream pain relief cream

Nature's Health Connection has announced record sales of their Australian Dream pain relief cream. After a successful television advertising campaign produced by CPG specialists Western Creative, Inc. that highlights Australian Dream's Empty Jar Guarantee, unit retail sales of the product have increased an astonishing 145% over the course of the last year.

18 Mar 2011

Science journal publishes CYTK preclinical cardiac myosin activation research results

Cytokinetics, Incorporated announced today the publication of preclinical research in the March 18, 2011 issue of the journal Science regarding the activation of cardiac myosin by an investigational drug candidate, omecamtiv mecarbil, and the potential therapeutic role that this novel mechanism may play for patients with systolic heart failure.

18 Mar 2011

Despite obesity epidemic life expectancy rises in Europe

Life expectancy in Europe keeps increasing despite the obesity epidemic, with people in Britain reaching an older age than those living in the US, according to an analysis of trends over the last 40 years.

18 Mar 2011

KYTHERA presents additional data from third ATX-101 Phase II clinical study in submental fat reduction

KYTHERA Biopharmaceuticals, Inc. today presented additional efficacy data from a third Phase II clinical study with ATX-101, a first-in-class adipolytic agent that is under investigation for the reduction of submental ('under the chin') fat. The expanded analysis focused on additional patient reported outcome measures, including instruments measuring submental fat impact, subject global assessments and subject self-ratings of chin attractiveness.

18 Mar 2011

Behavior prediction may help people strengthen existing habits

If you ask people how much they plan to exercise, they'll exercise more-but only if that's a personal goal, according to a new study in the Journal of Consumer Research.

18 Mar 2011

Modified mRNA raises hope for safe and effective cancer drugs

Modern gene therapies raise hopes of combating many diseases until now considered terminal. Nowadays, however, the methods are expensive and carry a risk of severe complications.

18 Mar 2011

Scientists develop California's first detailed neighborhood database on cancer

Does living in a low-income, densely populated neighborhood such as San Francisco's Tenderloin district predispose you to a higher cancer risk than if you live in an upscale and suburban neighborhood such as San Diego's Rancho Santa Fe? Or vice versa? Scientists at the Cancer Prevention Institute of California now have the data that hold the answers.

18 Mar 2011

FDA advisory panel votes in favor of NovoTTF-100A System for supra-tentorial glioblastoma multiforme tumors

Novocure announced today that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted (7 yes; 3 no; 2 abstain) that for patients with supra-tentorial glioblastoma multiforme (GBM) tumors that recur after maximal surgical and radiation treatments, there is reasonable assurance that the benefits of the NovoTTF-100A System (NovoTTF) outweigh its risks when administered as a monotherapy in place of standard medical therapy.

18 Mar 2011

Transcranial LED-based light therapy improves cognitive function in traumatic brain injury patients

At-home, daily application of light therapy via light-emitting diodes (LEDs) placed on the forehead and scalp led to improvements in cognitive function and post-traumatic stress disorder in patients with a traumatic brain injury (TBI), according to a groundbreaking study published in Photomedicine and Laser Surgery, a peer-reviewed journal published by Mary Ann Liebert, Inc.

18 Mar 2011

Pilot study shows feasibility of heart screening for risk of SCA in children

A pilot study in healthy children and adolescents shows that it is feasible to screen for undiagnosed heart conditions that increase the risk of sudden cardiac arrest.

18 Mar 2011

$Guide to improving care of baby boomers' fragility fractures$

Guide to improving care of baby boomers' fragility fractures

Many Baby Boomers will experience a bone fracture as they age, and the current US healthcare system is not prepared to provide the necessary care required, according to a special monograph released in the January 2011 issue of Geriatric Orthopaedic Surgery and Rehabilitation (GOS), published by SAGE.

18 Mar 2011

Medical Condition News

PixelOptics launches world's first electronically-focusing prescription eyewear

Retina Implant to join with Wills Eye for U.S. artificial vision clinical trial

Experts to present latest information on multiple myeloma at Patient Symposium

Autism Speaks supports ICM-9-CM diagnostic code for ASD detection in children

Researchers discover a type of 'cellular bilingualism' in brain

Medicare officials signal no payment changes on anemia drugs

GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference

Non-adherence to chronic opioid therapy increases healthcare costs and hospital days

AANMA survey details the impact of asthma and allergies on patients and their families

Nature's Health announces record sales of 145% for Australian Dream pain relief cream

Science journal publishes CYTK preclinical cardiac myosin activation research results

Despite obesity epidemic life expectancy rises in Europe

KYTHERA presents additional data from third ATX-101 Phase II clinical study in submental fat reduction

Behavior prediction may help people strengthen existing habits

Modified mRNA raises hope for safe and effective cancer drugs

Scientists develop California's first detailed neighborhood database on cancer

FDA advisory panel votes in favor of NovoTTF-100A System for supra-tentorial glioblastoma multiforme tumors

Transcranial LED-based light therapy improves cognitive function in traumatic brain injury patients

Pilot study shows feasibility of heart screening for risk of SCA in children

Guide to improving care of baby boomers' fragility fractures

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News